|
|
||||||||


*
Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia;
Ozgene Pty, Nedlands, Western Australia, Australia; and
Department of Immunology, Allergy, and Arthritis, Flinders Medical Center, Bedford Park, South Australia, Australia
MHC class II haplotypes control the specificity of Th immune
responses and susceptibility to many autoimmune diseases. Understanding
the role of HLA class II haplotypes in immunity is hampered by the lack
of animal models expressing these genes as authentic
cis-haplotypes. In this study we describe transgenic
expression of the autoimmune prone HLA DR3-DQ2 haplotype from a yeast
artificial chromosome (YAC) containing an intact
320-kb region from
HLA DRA to DQB2. In YAC-transgenic mice HLA DR and DQ gene products
were expressed on B cells, macrophages, and dendritic cells, but not on
T cells indicating cell-specific regulation. Positive selection of the
CD4 compartment by human class II molecules was 67% efficient in
YAC-homozygous mice lacking endogenous class II molecules
(A
null/null) and expressing only murine CD4. A
broad range of TCR V
families was used in the peripheral T cell
repertoire, which was also purged of V
5-, V
11-, and
V
12-bearing T cells by endogenous mouse mammary tumor virus-encoded
superantigens. Expression of the HLA DR3-DQ2 haplotype on the
A
null/null background was associated with normal
CD8-dependent clearance of virus from influenza-infected mice and
development of CD4-dependent protection from otherwise lethal infection
with Salmonella typhimurium. HLA DR- and DQ-restricted T
cell responses were also elicited following immunization with known T
cell determinants presented by these molecules. These findings
demonstrate the potential for human MHC class II haplotypes to function
efficiently in transgenic mice and should provide valuable tools for
developing humanized models of MHC-associated autoimmune
diseases.
This article has been cited by other articles:
![]() |
A. L. de Kauwe, Z. Chen, R. P. Anderson, C. L. Keech, J. D. Price, O. Wijburg, D. C. Jackson, J. Ladhams, J. Allison, and J. McCluskey Resistance to Celiac Disease in Humanized HLA-DR3-DQ2-Transgenic Mice Expressing Specific Anti-Gliadin CD4+ T Cells J. Immunol., June 15, 2009; 182(12): 7440 - 7450. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stickler, N. Rochanayon, O. J. Razo, J. Mucha, W. Gebel, N. Faravashi, R. Chin, S. Holmes, and F. A. Harding An In Vitro Human Cell-Based Assay to Rank the Relative Immunogenicity of Proteins Toxicol. Sci., February 1, 2004; 77(2): 280 - 289. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |